DR Market News Briefs

European ADRs Fractionally Higher as Banks Log Gains


Last updated: 05/18/2017 11:02:14

11:02 AM EDT, 05/18/2017 (MT Newswires) --

Gainers in Continental Europe were led by Criteo (CRTO), a French technology company, 3.3% higher, followed by Nabriva Therapeutics (NBRV), an Austria-based clinical-stage biopharmaceutical company, up by 3.1% and Cellectis (CLLS), a French genome engineering company, 1.7% higher. TiGenix (TIG), a Belgium-based biopharmaceutical company, was up by 1.5%.

In the UK, Shire (SHPG), a biopharmaceutical company, was 4.7% higher, followed by Royal Bank of Scotland (RBS), up by 3% and Trinity Biotech (TRIB), a manufacturer of medical diagnostic products, up by 2.8%. Barclays Bank (BCS) was 2.3% higher.

Decliners in Continental Europe were led by Telecom Italia (TI), down by 3.5%, followed by CGG (CGG), a manufacturer of geophysical equipment, 3.1% lower and Banco Santander (SAN) and AB InBev (BUD), a Belgium-based company engaged in the brewers industry, both 2.7% lower.

And, in the UK, Adaptimmune Therapeutics (ADAP), a clinical-stage biopharmaceutical company, was down by 2.9%, followed by Randgold Resources (GOLD), a gold-mining company, 2.4% lower and Fly Leasing (FLY), an aircraft leasing company, down by 1.3%. Akari Therapeutics (AKTX), a development-stage biopharmaceutical company, was 1.2% lower.

Price: 49.90, Change: +0.96, Percent Change: +1.96

Copyright © 2017 MTNewswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

Quotes displayed with 15 minutes delay. Market data provided by ICE Data Services ICE Limitations. Powered and implemented by FactSet. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Hemscott equity data provided by Morningstar, Inc. Earnings Calendar and Events Data provided by Wall Street Horizon. © 2017 Wall Street Horizon, Inc.